Annual Cash & Cash Equivalents
$26.33 M
-$17.49 M-39.91%
December 31, 2023
Summary
- As of March 6, 2025, CRDL annual cash & cash equivalents is $26.33 million, with the most recent change of -$17.49 million (-39.91%) on December 31, 2023.
- During the last 3 years, CRDL annual cash & cash equivalents has risen by +$15.33 million (+139.41%).
- CRDL annual cash & cash equivalents is now -59.98% below its all-time high of $65.80 million, reached on December 31, 2021.
Performance
CRDL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$11.76 M
-$5.78 M-32.96%
September 30, 2024
Summary
- As of March 6, 2025, CRDL quarterly cash and cash equivalents is $11.76 million, with the most recent change of -$5.78 million (-32.96%) on September 30, 2024.
- Over the past year, CRDL quarterly cash and cash equivalents has stayed the same.
- CRDL quarterly cash and cash equivalents is now -82.13% below its all-time high of $65.80 million, reached on December 1, 2021.
Performance
CRDL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CRDL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.9% | 0.0% |
| 3 y3 years | +139.4% | 0.0% |
| 5 y5 years | +114.3% | 0.0% |
CRDL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.0% | at low | -80.4% | at low |
| 5 y | 5-year | -60.0% | +394.5% | -82.1% | +270.8% |
| alltime | all time | -60.0% | +1305.1% | -82.1% | +527.4% |
Cardiol Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.76 M(-33.0%) |
| Jun 2024 | - | $17.54 M(-17.1%) |
| Mar 2024 | - | $21.15 M(-19.7%) |
| Dec 2023 | $26.33 M(-39.9%) | $26.33 M(-11.7%) |
| Sep 2023 | - | $29.82 M(-12.1%) |
| Jun 2023 | - | $33.91 M(-7.3%) |
| Mar 2023 | - | $36.57 M(-16.5%) |
| Dec 2022 | $43.82 M(-33.4%) | $43.82 M(-8.6%) |
| Sep 2022 | - | $47.92 M(-12.4%) |
| Jun 2022 | - | $54.68 M(-8.8%) |
| Mar 2022 | - | $59.95 M(-8.9%) |
| Dec 2021 | $65.80 M | - |
| Dec 2021 | - | $65.80 M(+192.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $22.46 M(-14.9%) |
| Jun 2021 | - | $26.39 M(+85.0%) |
| Mar 2021 | - | $14.26 M(+29.7%) |
| Dec 2020 | $11.00 M(+106.5%) | $11.00 M(-11.0%) |
| Sep 2020 | - | $12.36 M(-13.1%) |
| Jun 2020 | - | $14.23 M(+348.7%) |
| Mar 2020 | - | $3.17 M(-40.5%) |
| Dec 2019 | $5.33 M(-56.6%) | $5.33 M(-30.2%) |
| Sep 2019 | - | $7.63 M(-19.6%) |
| Jun 2019 | - | $9.49 M(-11.4%) |
| Mar 2019 | - | $10.71 M(-12.8%) |
| Dec 2018 | $12.28 M(+555.5%) | $12.28 M(+36.1%) |
| Sep 2018 | - | $9.03 M(+381.8%) |
| Dec 2017 | $1.87 M | $1.87 M |
FAQ
- What is Cardiol Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual cash & cash equivalents year-on-year change?
- What is Cardiol Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Cardiol Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CRDL is $26.33 M
What is the all time high annual cash & cash equivalents for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual cash & cash equivalents is $65.80 M
What is Cardiol Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CRDL annual cash & cash equivalents has changed by -$17.49 M (-39.91%)
What is Cardiol Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CRDL is $11.76 M
What is the all time high quarterly cash and cash equivalents for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly cash and cash equivalents is $65.80 M
What is Cardiol Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CRDL quarterly cash and cash equivalents has changed by $0.00 (0.00%)